Stock Symbol ISRG: A Comprehensive Overview

ISRG is the stock symbol for Intuitive Surgical, a company that's revolutionizing the medical industry. Founded in 1995, ISRG has been at the forefront of robotic-assisted surgery.

Their flagship product, the da Vinci Surgical System, is a game-changer in the operating room. This robotic system allows surgeons to perform complex procedures with enhanced precision and control.

With over 6,000 systems installed worldwide, ISRG's technology has improved patient outcomes and reduced recovery times. Their commitment to innovation has made them a leader in the medical device industry.

ISRG's stock has been a consistent performer, with a strong track record of growth and stability.

Readers also liked: Stock Symbol B

Analysts are overwhelmingly positive about Intuitive Surgical, with an average rating of "Strong Buy" from 19 analysts.

The average estimate for ISRG stock is $1.37, based on 10 estimates from various analysts.

Analysts are expecting a significant increase in earnings, with a growth rate estimated at 18.10% year over year.

The 12-month stock price forecast is $578.94, representing an increase of 1.24% from the latest price.

Here's a breakdown of the analyst estimates:

Analysts have consistently raised their forecasts for Intuitive Surgical, following strong Q4 results.

Intuitive Surgical's revenue reached a record high of $8.35 billion in 2024, marking a 17.24% increase from the previous year.

The company's earnings also saw significant growth, jumping 29.18% to $2.32 billion.

Intuitive Surgical's stock price has been on the rise, with a market cap of $203.965 billion.

Here's a breakdown of the company's financial performance:

The stock's previous close was $580.18, with a day range of $570.86 to $586.89.

The average earnings estimate for Intuitive Surgical is $1.37 per share, based on 10 analyst estimates.

Analysts are optimistic about the company's future performance, with a growth rate estimated to be 18.10% year over year.

The average revenue estimate for the company is $2.25 billion.

Intuitive Surgical has received a "Strong Buy" rating from 19 analysts, with a 12-month stock price forecast of $578.94.

Here's a summary of the average estimates:

The number of analysts covering the company has increased, with 25 analysts covering the company in the current quarter.

Here's a breakdown of the average estimates for the next few quarters:

Intuitive Surgical, Inc. is an American corporation that develops and markets robotic products for minimally invasive surgery. The company is headquartered in California and operates in the US, Western Europe, the Asia Pacific regions, and China through a joint venture with Fosun Pharma.

Intuitive Surgical was established in 1995 and went public in 2000, trading on the Nasdaq stock exchange under the ticker symbol ISRG. The company's main product is the da Vinci Surgical System, which helps physicians and healthcare providers conduct complex surgery with the help of robots.

The da Vinci Surgical System reduces variability in surgery and helps deliver better care and early recovery for patients. Intuitive Surgical also designed and developed Ion, a robot-assisted endoluminal platform for performing peripheral lung biopsies.

Intuitive Surgical, Inc. is a developer of minimally invasive, robot-assisted surgery. The company is headquartered in California and operates across the US, Western Europe, and the Asia Pacific regions.

Established in 1995, Intuitive Surgical has a long history of innovation in the field of medical technology. It operates in China through Intuitive Fosun, a joint venture with Fosun Pharma.

The company's flagship product is the da Vinci Surgical System, which helps physicians and healthcare providers conduct complex surgery with the help of robots. This system reduces variability in surgery and helps deliver better care and early recovery.

Intuitive Surgical also designed and developed Ion, a robot-assisted endoluminal platform. This platform is designed to perform peripheral lung biopsies with the help of an advanced ultra-thin, ultra-manoeuvrable catheter.

Here are some key facts about Intuitive Surgical:

Intuitive Surgical went public in 2000, trading on the Nasdaq stock exchange under the ticker symbol ISRG.

Intuitive Surgical has a diverse and experienced management team, with several key executives holding important positions.

Craig H. Barratt serves as the Chairman of the company, overseeing the overall direction and strategy of Intuitive Surgical.

Gary S. Guthart is the Chief Executive Officer & Director, responsible for leading the company's day-to-day operations and making key decisions.

Brian E. Miller holds the position of Chief Digital Officer & Executive Vice President, focusing on digital transformation and innovation within the company.

Jamie E. Samath serves as the Chief Financial Officer & Executive Vice President, overseeing the company's financial planning and strategy.

Here are some key executives and their roles:

The company also has several independent directors, including Amal M. Johnson, Amy L. Ladd, Monica P. Reed, Keith R. Leonard, Jami K. Dover Nachtsheim, Joseph C. Beery, Mark J. Rubash, and David J. Rosa.